Deal-Making

Nona Biosciences and Alaya.bio have partnered to reprogram cells in-situ to improve development, production and administration of CAR-T cell therapies.

Deal Making

Receiving clearance from regulatory authorities, Thermo Fisher has acquired proteonomic-focused firm Olink for an estimated $3.1 billion.

Facilities & Capacity

Rentschler has opened its production line at its 22,000 square-feet facility in Milford, Massachusetts, about 20 miles southwest of Boston.

Facilities & Capacity

Avid Bioservices says it has doubled gross margin quarter-on-quarter due to capital expenditure projects – including a 53,000 square-foot viral vector plant – coming online.

Global Markets

The BIOSECURE Act is back in the news following a speech by the Speaker of the House, Mike Johnson, who vowed to pass the bill before the end of the year.

Global Markets

Sanofi will supply bulk inactivated polio vaccines (IPV) to Biovac, which will carry out final formulation, fill/finish, and quality control in Africa, for Africa, under terms of the partnership.

Regulations

The BIOSECURE Act is back in the news following a speech by the Speaker of the House, Mike Johnson, who vowed to pass the bill before the end of the year.

Regulations

CDMO Aurobindo’s Telangana, India facility has been classified as Voluntary Action Indicated (VAI) following a Form 483 with seven observations.

Therapeutic Class

J&J has agreed to pay $50 million to CDMO Emergent BioSolutions for a terminated COVID-19 vaccine contract following a two-year long dispute.

Facilities & Capacity

Avid Bioservices says it has doubled gross margin quarter-on-quarter due to capital expenditure projects – including a 53,000 square-foot viral vector plant – coming online.

Upstream & Downstream Processing

The International Chinese hamster ovary (CHO) genome community has won the European Society for Animal Cell Technology (ESACT) Innovation Award in Edinburgh, UK.

Upstream & Downstream Processing

Alan Dickson, professor at The University of Manchester and chair of the European Society for Animal Cell Technology (ESACT), led the opening plenary for the 28th ESACT meeting in Edinburgh, UK.